healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.
The virtual care model isn’t perfect, but it can “effectively address the needs of challenging patient populations, including those requiring virtual management of controlled substances,” according to Joseph Kvedar, MD, Senior Advisor of Virtual Care at Mass General Brigham.
Taking economics out of the picture, the value proposition that tips the scales for telehealth is quality, according to Joseph Kvedar, MD, who cites examples where “we can extend access, provide patient convenience, and do so at a higher quality than in-person.”
Telehealth can play a much bigger role in improving care and satisfaction. But until it becomes more attractive to physicians, that potential may never be reached, according to Joseph Kvedar, MD, Senior Advisor of Virtual Care at Mass General Brigham.
As the viability of long-term telehealth reimbursement continues to hang in the balance, how can healthcare organizations prepare? What can leaders reasonably expect? Joe Kvedar, MD, shares his thoughts.
It’s hard to think that machines might do some tasks better than humans – especially clinicians who have trained for years to develop higher cortical skills. But they can, says Dr. Joseph Kvedar, especially when recognizing patterns in large data sets and using them to make predictions.
